---
title: "Continuous Manufacturing: Moving from Promise to Commercial Reality"
description: In this webcast, learn about opportunities and challenges for implementing continuous manufacturing strategies for flexibility across the product lifecycle.
---

[![BPI Media_Logo 2_Color 1](https://bpi.bioprocessintl.com/hs-fs/hubfs/BPI%20Media_Logo%202_Color%201.png?width=350&height=161&name=BPI%20Media_Logo%202_Color%201.png)](https://bioprocessintl.com/)

#                                          ![BPI Media_AsktheExpert_590 x 197_Header_for_Landing_Pages](https://bpi.bioprocessintl.com/hs-fs/hubfs/BPI%20Media_AsktheExpert_590%20x%20197_Header_for_Landing_Pages.jpg?width=543&height=181&name=BPI%20Media_AsktheExpert_590%20x%20197_Header_for_Landing_Pages.jpg)

# Continuous Manufacturing:

# Moving from Promise to Commercial Reality

|  |
| --- |

## Presenter:

****![07-09-2026-Fujifilm-ATE-HS](https://bpi.bioprocessintl.com/hs-fs/hubfs/07-09-2026-Fujifilm-ATE-HS.png?width=160&height=231&name=07-09-2026-Fujifilm-ATE-HS.png)****

**Leon Pybus**

*Director, CHO Bioprocess Science,*

FUJIFILM Biotechnologies

 

Dr. Leon Pybus is director of CHO bioprocess science at FUJIFILM Biotechnologies, where he leads the development and implementation of innovative CHO cell culture technologies across the global network. With over 15 years of experience spanning cell line development, upstream process development and CMC strategy, Leon has contributed to the advancement of next-generation biologics manufacturing platforms, including intensified and continuous bioprocessing approaches. He is an active industry contributor, with numerous peer-reviewed publications and invited presentations at international conferences focused on cell culture engineering, bioprocess development, and biologics manufacturing.

## About this event:

#### Date: July 9, 2026

#### Time: 11 am EDT | 8 am PDT | 5 pm CEST

#### Duration: 30 minutes

As biologics pipelines become increasingly diverse and demand patterns more difficult to predict, manufacturing flexibility has become a critical success factor. Continuous manufacturing and process intensification offer new opportunities to increase operational agility, optimize facility utilization, and respond more effectively to changing commercial requirements while reducing facility footprint and resource consumption to potentially lower environmental impact without compromising product quality or supply reliability. 

Drawing on FUJIFILM Biotechnologies’ MaruX™ approach, the webcast will examine how:

- Continuous bioprocessing can help move beyond traditional batch constraints.
- Intensified CHO manufacturing platforms can provide the flexibility to support both current and future production needs.
- Smart use of manufacturing capacity benefits both mAbs and more complex, labile molecules.

Through practical examples, learn about opportunities, challenges, and real-world considerations for implementing continuous manufacturing strategies for flexibility across the product lifecycle.

Register now to learn how MaruX™ provides flexibility of scale, helping innovators adapt with confidence as products, markets, and demand evolve.

-  

-  

©2015 BioProcess International All Rights reserved